Tuberculosis
Lilly Announces Additional US$50 Million Investment in Global Tuberculosis Partnership
Published in Lab Business Week, April 8th, 2007
Eli Lilly and Company (NYSE: LLY) today announced plans to invest an additional US$50 million in an innovative, global partnership to fight Multi- Drug Resistant Tuberculosis (MDR-TB). The announcement is being made in conjunction with World TB Day activities.
This new commitment furthers Lilly's support of a pioneering initiative started in 2003, and brings the total Lilly investment to US$120 million. The funding supports a multi-pronged strategy to increase the supply and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-04-08)
More Articles from Lab Business Week
- Bone Research
Unigene's Site-Directed Bone Growth Technology May Have Multiple Large Market Applications According to New Market Analysis - Cancer
Ranbaxy Rewards Excellence In Medical And Pharmaceutical Research - Kirkegaard & Perry Laboratories
KPL Receives ISO 9001:2000 Registration - Life Sciences
Researchers from Kenton Laboratories provide details of new studies and findings in the area of life sciences - Life Sciences
Researchers from Moss Landing Marine Laboratories detail findings in life sciences - Marketing and Licensing Agreements
Commonwealth Drugs & Medical Supplies Co. Ltd. to Sell Jamieson Natural Supplements in the Bahamas - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
